WhaleQuant.io
Abbott Laboratories (ABT) Corporate Logo

Abbott Laboratories (ABT) Stock Price & Analysis

Market: NYSE • Sector: Healthcare • Industry: Medical - Devices

Abbott Laboratories (ABT) Profile & Business Summary

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Key Information

Ticker ABT
Exchange NYSE
Official Site https://www.abbott.com
CIK Number 0000001800
View SEC Filings

Market Trend Overview for ABT

One model, two time views: what the market looks like right now, and where the larger trend is heading over time.

Longer-Term Market Trend (Mid to Long Term)

Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-07-20 (ET)

As of 2026-07-20, ABT is in a strong upward move. Over the longer term, the trend remains bearish.

ABT last closed at 101.66. The price is about 3.8 ATR above its recent average price (93.20), and the market is currently in a strong upward move. Price at 101.66 is holding above minor support near 100.88. If price continues higher, it may face minor resistance around 103.84. View Support & Resistance from Options

Short-term strength is developing against a weaker long-term trend, which increases the risk of downside reversals.

Trend Alignment Summary

Trend score: 70 out of 100. Overall alignment is moderate. The market is currently in a strong and established uptrend. Some trend alignment is present, but the structure is still forming.

Pullback Risk

Price is stretched well above its recent average (about 3.8 ATR). Upside extension is elevated, and chasing strength here carries a higher pullback risk.

Key Risk Level

A key downside risk boundary is near 85.20. If price falls below this area, the current structure would likely weaken further.

Recent Trend Signal

A systematic trend-activation signal was most recently triggered on 2026-07-16, reflecting a technical shift toward positive directional alignment.

Unusual Price Movement

[2026-07-10] Price moved quickly and looked strong, but participation was limited.

Recent Price Behavior

Recent price action shows orderly upward progression with no major deterioration in bar-level efficiency. Structural conditions remain broadly constructive.

Overnight Positioning

There was no clear sign of meaningful positions being carried into the overnight session.

Next-day directional probability forecast Last updated: 2026-07-20 (ET)
Next-session outlook for 2026-07-21 (ET)
Bullish lean, but not actionable

What the model sees

The model does not deploy the setup because the current position looks stretched and more vulnerable to pullback or digestion.


Why the model says this

The model does not deploy this setup because extension risk is 82%, pullback risk is 67%, and recent price behavior has shown failed reversal memory. Predictability is 55%, agreement is 93%, and reversal risk is 30%.

NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history

Recent Cost Distribution Last updated: 2026-07-20 (ET)

This reading is based on the last 20 trading days of 15-minute price, volume, and VWAP data. Price is trading 6.1% above the recent estimated cost basis of 95.80, which keeps the recent cost structure in a clearly stronger position. Price is in the upper half of the main cost band (98.45 to 102.22), which is usually a healthier short-term location because price is holding the stronger side of recent trading activity. The lower down support area sits around 98.35 to 99.18. It looks more like a first buffer than a major floor. About 94% of recent positioning is in profit, which is a strong backdrop, but it also means momentum needs to stay healthy to avoid profit-taking pressure. The main cost band is fairly wide relative to recent ATR, so this structure may behave less cleanly than a tighter setup. From a trading point of view, the trend still has support, but because the main support sits lower down around 98.35 to 99.18, the key is whether pullbacks remain controlled before dropping back into that zone.

Analytical Modules